TY - JOUR
KW - Adult
KW - Antidepressive Agents/economics
KW - Depressive Disorder/economics/therapy
KW - Disease Management
KW - Female
KW - Financing, Personal
KW - Health Maintenance Organizations/economics
KW - Health Services Research
KW - Humans
KW - Male
KW - Middle Aged
KW - Patient Acceptance of Health Care/psychology
KW - Primary Health Care/economics
KW - Psychotherapy/economics
KW - Value of Life/economics
KW - Washington
AU - J. Unutzer
AU - W. J. Katon
AU - J. Russo
AU - G. Simon
AU - M. Von Korff
AU - E. Lin
AU - E. Walker
AU - E. Ludman
AU - T. Bush
A1 - 
AB - OBJECTIVE: The authors analyzed data from 615 depressed primary care patients to determine their willingness to pay for depression treatment. METHODS: A sample of 615 adult patients from four primary care clinics participated in a randomized controlled trial of a disease management program for depression in primary care. Participants were asked at baseline interviews and six-month follow-up interviews how much they would be willing to pay per month for a six-month treatment that would eliminate their symptoms of depression. Multiple regression analyses were used to estimate the association between demographic and clinical factors and willingness to pay for depression treatment and to examine changes. RESULTS: The mean amount that participants were willing to pay for depression treatment at baseline was $270+/-187 per month, or about 9 percent of the participants' household income. Willingness to pay was significantly associated with household income and with the severity of depressive symptoms. Over six months, the amount that participants were willing to pay decreased along with their severity of depressive symptoms. CONCLUSIONS: The amount that participants were willing to pay was comparable to that reported for the treatment of other chronic medical disorders and higher than the actual cost of depression treatment. Measurements of willingness to pay may be a promising method for assessing the value of treatments for common mental disorders.
BT - Psychiatric services (Washington, D.C.)
C5 - Financing & Sustainability
CP - 3
CY - United States
IS - 3
JF - Psychiatric services (Washington, D.C.)
N2 - OBJECTIVE: The authors analyzed data from 615 depressed primary care patients to determine their willingness to pay for depression treatment. METHODS: A sample of 615 adult patients from four primary care clinics participated in a randomized controlled trial of a disease management program for depression in primary care. Participants were asked at baseline interviews and six-month follow-up interviews how much they would be willing to pay per month for a six-month treatment that would eliminate their symptoms of depression. Multiple regression analyses were used to estimate the association between demographic and clinical factors and willingness to pay for depression treatment and to examine changes. RESULTS: The mean amount that participants were willing to pay for depression treatment at baseline was $270+/-187 per month, or about 9 percent of the participants' household income. Willingness to pay was significantly associated with household income and with the severity of depressive symptoms. Over six months, the amount that participants were willing to pay decreased along with their severity of depressive symptoms. CONCLUSIONS: The amount that participants were willing to pay was comparable to that reported for the treatment of other chronic medical disorders and higher than the actual cost of depression treatment. Measurements of willingness to pay may be a promising method for assessing the value of treatments for common mental disorders.
PP - United States
PY - 2003
SN - 1075-2730; 1075-2730
SP - 340
EP - 345
EP - 
T1 - Willingness to pay for depression treatment in primary care
T2 - Psychiatric services (Washington, D.C.)
TI - Willingness to pay for depression treatment in primary care
U1 - Financing & Sustainability
U2 - 12610241
VL - 54
VO - 1075-2730; 1075-2730
Y1 - 2003
ER -